نتایج جستجو برای: duloxetine

تعداد نتایج: 1193  

2017
ANTONIO DEL CASALE PAOLO GIRARDI ROBERTO BRUGNOLI GABRIELE SANI CHIARA BRUGNOLI FEDERICA CACCIA GLORIA ANGELETTI CHIARA RAPINESI ROBERTO TATARELLI GEORGIOS D. KOTZALIDIS

Introduction. The elderly population is more frequently subjected to depressive mood compared to the general population and show peculiarities affecting responsiveness; furthermore, aged people need also special care. Duloxetine is a relatively new antidepressant that proved to be effective in adult depression, but has received little attention in elderly populations heretofore. Aim. To review ...

Journal: :Neuropsychiatric Disease and Treatment 2008
Domenico De Berardis Nicola Serroni Alessandro Carano Marco Scali Alessandro Valchera Daniela Campanella Alessandro D’Albenzio Berardo Di Giuseppe Francesco Saverio Moschetta Rosa Maria Salerno Filippo Maria Ferro

Anxiety disorders (ADs) are the most common type of psychiatric disorders, with a mean incidence of 18.1% and a lifetime prevalence of 28.8%. Pharmacologic options studied for treating ADs may include benzodiazepines, tricyclic antidepressants (TCA), selective serotonin reuptake inhibitors (SSRIs), noradrenergic and specific serotonergic drug (NaSSA) and dual-reuptake inhibitors of serotonin an...

Journal: :JAMA 2013
Ellen M Lavoie Smith Herbert Pang Constance Cirrincione Stewart Fleishman Electra D Paskett Tim Ahles Linda R Bressler Camilo E Fadul Chetaye Knox Nguyet Le-Lindqwister Paul B Gilman Charles L Shapiro

IMPORTANCE There are no known effective treatments for painful chemotherapy-induced peripheral neuropathy. OBJECTIVE To determine the effect of duloxetine, 60 mg daily, on average pain severity. DESIGN, SETTING, AND PATIENTS Randomized, double-blind, placebo-controlled crossover trial at 8 National Cancer Institute (NCI)-funded cooperative research networks that enrolled 231 patients who we...

2017
Mingxin Zhang Hanzhong Li Zhigang Ji Dexin Dong Su Yan

To explore the safety and efficacy of the selective 5-serotonin and norepinephrine reuptake inhibitor duloxetine hydrochloride and alpha-adrenergic receptor blocker (alpha-blocker) doxazosin mesylate-controlled tablets in the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).In all, 150 patients were enrolled and 126 patients completed the study (41 patien...

2013
Joseph L Micca Dustin Ruff Jonna Ahl Madelaine M Wohlreich

BACKGROUND Osteoarthritis (OA) knee pain is common in older patients and contributes to decreased quality of life. Older patients are generally at higher risk of adverse drug reactions due to age-related changes in physiology that affect drug disposition, metabolism, and response. These analyses examined efficacy and safety outcomes of older (≥65 years) versus younger patients from clinical tri...

2012
Yang Zhao Peter Sun Mark Bernauer

BACKGROUND The purpose of this study was to examine the main reasons for inpatient or outpatient visits after initiating duloxetine or pregabalin. METHODS Commercially insured patients with fibromyalgia and aged 18-64 years who initiated duloxetine or pregabalin in 2006 with 12-month continuous enrollment before and after initiation were identified. Duloxetine and pregabalin cohorts with simi...

Journal: :American journal of obstetrics and gynecology 2002
Peggy A Norton Norman R Zinner Ilker Yalcin Richard C Bump

OBJECTIVE The purpose of this study was to assess the efficacy and safety of duloxetine, a selective inhibitor of serotonin and norepinephrine reuptake, in the treatment of stress urinary incontinence. STUDY DESIGN A double-blind, randomized, placebo-controlled study was conducted in 553 women aged 18 to 65 years with a predominant symptom of stress urinary incontinence. Subjects were randomi...

Journal: :British journal of pharmacology 2011
T Mixcoatl-Zecuatl C G Jolivalt

BACKGROUND AND PURPOSE This study was designed to clarify mechanisms responsible for the anti-allodynic effects of duloxetine in diabetes. EXPERIMENTAL APPROACH The streptozotocin-induced diabetic rat model was used to compare the efficacy of duloxetine, 5-HT, the 5-HT(2A) receptor agonist [1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane hydrochloride (DOI)] and two antagonists (ketanserin and ...

2009
Ahsan Y Khan Matthew Macaluso

Approximately 16 million people in the United States suffer from anxiety disorders alone, while another 12 million experience both anxiety and at least one other psychiatric condition. Generalized anxiety disorder (GAD) has lifetime prevalence rates between 5% and 6%. Treatment of GAD is aimed primarily at symptom reduction. Duloxetine, a serotonin norepinephrine reuptake inhibitor (SNRI), rece...

Journal: :Psychiatria Danubina 2010
Glen I Spielmans

A recent narrative review by Mohr et al. (2010) states that duloxetine possesses “consistent analgesic efficacy” in reducing pain among depressed patients. They claim that this finding runs counter to my allegedly “controversial” meta-analysis which found that duloxetine possessed no such analgesic benefits in depression (Spielmans 2008). Yet their paper did not contain any statistical analysis...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید